BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 19460325)

  • 1. Population biology of the human restricted pathogen, Streptococcus pyogenes.
    Bessen DE
    Infect Genet Evol; 2009 Jul; 9(4):581-93. PubMed ID: 19460325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular epidemiology and genomics of group A Streptococcus.
    Bessen DE; McShan WM; Nguyen SV; Shetty A; Agrawal S; Tettelin H
    Infect Genet Evol; 2015 Jul; 33():393-418. PubMed ID: 25460818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Epidemiology, Ecology, and Evolution of Group A Streptococci.
    Bessen DE; Smeesters PR; Beall BW
    Microbiol Spectr; 2018 Sep; 6(5):. PubMed ID: 30191802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population and Whole Genome Sequence Based Characterization of Invasive Group A Streptococci Recovered in the United States during 2015.
    Chochua S; Metcalf BJ; Li Z; Rivers J; Mathis S; Jackson D; Gertz RE; Srinivasan V; Lynfield R; Van Beneden C; McGee L; Beall B
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global genomic epidemiology of Streptococcus pyogenes.
    Jespersen MG; Lacey JA; Tong SYC; Davies MR
    Infect Genet Evol; 2020 Dec; 86():104609. PubMed ID: 33147506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in epidemiologic characteristics and antimicrobial resistance of
    Ubukata K; Wajima T; Morozumi M; Sakuma M; Tajima T; Matsubara K; Itahashi K; Iwata S
    J Med Microbiol; 2020 Mar; 69(3):443-450. PubMed ID: 32011228
    [No Abstract]   [Full Text] [Related]  

  • 7. Group A streptococci. Erythromycin resistance and penicillin tolerance.
    Savoia D; Millesimo M; Dotti G; Milano F
    Adv Exp Med Biol; 1997; 418():447-9. PubMed ID: 9331690
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence of Streptococcus invasive locus (sil) and its relationship with macrolide resistance among group A Streptococcus strains.
    Billal DS; Hotomi M; Shimada J; Fujihara K; Ubukata K; Sugita R; Yamanaka N
    J Clin Microbiol; 2008 Apr; 46(4):1563-4. PubMed ID: 18287313
    [No Abstract]   [Full Text] [Related]  

  • 9. Rise and persistence of global M1T1 clone of Streptococcus pyogenes.
    Aziz RK; Kotb M
    Emerg Infect Dis; 2008 Oct; 14(10):1511-7. PubMed ID: 18826812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. emm typing, antibiotic resistance and PFGE analysis of Streptococcus pyogenes in Lebanon.
    Bahnan W; Hashwa F; Araj G; Tokajian S
    J Med Microbiol; 2011 Jan; 60(Pt 1):98-101. PubMed ID: 20864546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local changes in rates of group A Streptococcus disease and antibiotic resistance are associated with geographically widespread strain turnover events.
    Metzgar D; McDonough EA; Hansen CJ; Blaesing CR; Baynes D; Hawksworth AW; Blair PJ; Faix DJ; Russell KL
    Virulence; 2010; 1(4):247-53. PubMed ID: 21178449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Evolution of Clinical Pathogenic Streptococci.
    Li D; Tao C
    Curr Issues Mol Biol; 2019; 32():561-600. PubMed ID: 31166180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrolide-resistant Streptococcus pyogenes in Central Greece: prevalence; mechanism and molecular identification.
    Malli E; Tatsidou E; Damani A; Pantelidi K; Petinaki E; Skoulakis C; Drougka E; Spiliopoulou I
    Int J Antimicrob Agents; 2010 Jun; 35(6):614-5. PubMed ID: 20206477
    [No Abstract]   [Full Text] [Related]  

  • 14. Macrolide- and telithromycin-resistant Streptococcus pyogenes, Belgium, 1999-2003.
    Malhotra-Kumar S; Lammens C; Chapelle S; Wijdooghe M; Piessens J; Van Herck K; Goossens H
    Emerg Infect Dis; 2005 Jun; 11(6):939-42. PubMed ID: 15963292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Emergence of Hypervirulent M1T1 Clone of Group A
    Liu G
    Curr Issues Mol Biol; 2019; 32():435-472. PubMed ID: 31166177
    [No Abstract]   [Full Text] [Related]  

  • 16. High prevalence of fluoroquinolone-nonsusceptible Streptococcus pyogenes emm12 in Taiwan.
    Lin JN; Chang LL; Lai CH; Huang YH; Chen WF; Yang CH; Hsu J; Lin HH; Chen YH
    Diagn Microbiol Infect Dis; 2015 Oct; 83(2):187-92. PubMed ID: 26234479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythromycin resistance phenotypes in Swedish clinical isolates of group A streptococci.
    Jasir A; Schalén C
    Adv Exp Med Biol; 1997; 418():443-5. PubMed ID: 9331689
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence and molecular diversity of invasive Streptococcus dysgalactiae and Streptococcus pyogenes in a German tertiary care medical centre.
    Rößler S; Berner R; Jacobs E; Toepfner N
    Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1325-1332. PubMed ID: 29725958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interspecies recombination occurs frequently in quinolone resistance-determining regions of clinical isolates of Streptococcus pyogenes.
    Duesberg CB; Malhotra-Kumar S; Goossens H; McGee L; Klugman KP; Welte T; Pletz MW
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4191-3. PubMed ID: 18765693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid decrease in the prevalence of macrolide-resistant group A streptococci due to the appearance of two epidemic clones in Cantabria (Spain).
    Oliver MA; García-Delafuente C; Cano ME; Pérez-Hernández F; Martínez-Martínez L; Albertí S
    J Antimicrob Chemother; 2007 Aug; 60(2):450-2. PubMed ID: 17540676
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.